FDA Adverse Event Other Summary report: N

SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE

MDR report key: 2556509 · Received April 26, 2012

Report

Report Number
1220423-2012-00010
Event Type
Other
Date Received
April 26, 2012
Date of Event
March 7, 2012
Report Date
April 17, 2012
Manufacturer
GENZYME BIOSURGERY (SEPRAFILM/PACK)
Product Code
MCN
PMA / PMN Number
P950034
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

MFR'S COMMENT: THE BENEFIT-RISK RELATIONSHIP OF SEPRAFILM IS NOT AFFECTED BY THIS REPORT.

Description of Event or Problem · 1

RASHES [RASH]. SWELLING OF MOUTH [OEDEMA MOUTH]. DIFFICULTY BREATHING [DYSPNOEA]. CASE DESCRIPTION: SPONTANEOUS REPORT WAS RECEIVED ON (B)(4) 2012 FROM A PHYSICIAN VIA A COMPANY SALES REPRESENTATIVE REGARDING A FEMALE PATIENT, INITIALS (B)(6). THE PATIENT'S MEDICAL HISTORY WAS NOT PROVIDED. ON (B)(6) 2012, THE PATIENT UNDERWENT EXPLORATORY LAPAROTOMY WITH LYSIS OF ADHESIONS FOR SMALL BOWEL OBSTRUCTION. AT THE END OF THE SURGERY, SEPRAFILM WAS PLACED FOR POST-OPERATIVE ADHESIONS. WITHIN 12 HOURS OF THE OPERATION, THE PATIENT EXPERIENCED RASHES, SWELLING OF THE MOUTH, AND DIFFICULTY BREATHING. THE PATIENT WAS TREATED WITH IV STEROIDS AND BENADRYL (ROUTE OF ADMINISTRATION NOT PROVIDED). ALL PAIN MEDICATIONS AND ANTIBIOTICS WERE HELD. THE ACTION TAKEN WITH SEPRAFILM TREATMENT WAS NOT PROVIDED. THE OUTCOME OF THE EVENTS OF RASHES, SWELLING OF THE MOUTH, AND DIFFICULTY BREATHING WAS REPORTED BY PHYSICIAN AS: "THE PATIENT DOING WELL, DISCHARGED IN GOOD CONDITION ON POST OPERATIVE DAY # 8." CONCOMITANT MEDICATIONS WERE NOT PROVIDED. THE INTENSITY FOR THE EVENTS OF RASHES, SWELLING OF THE MOUTH, AND DIFFICULTY BREATHING WAS NOT PROVIDED. THE RELATIONSHIP BETWEEN SEPRAFILM AND THE EVENTS OF RASHES, SWELLING OF THE MOUTH, AND DIFFICULTY BREATHING WAS NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE BIORESORBABLE ADHESION BARRIER MCN GENZYME BIOSURGERY (SEPRAFILM/PACK) UNK UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention